Concord Biotech 1:1 bonus issue: record date set for 4 November 2026
Concord Biotech bonus issue record date is 4 November 2026 for a 1:1 bonus, one new share for each share held, per the company's 27 October filing.
The Concord Biotech bonus issue record date is Wednesday, 4 November 2026. In an intimation filed with the exchanges on 27 October 2026, the company said its board fixed that date at a meeting the same day. The bonus is in the ratio of 1:1, which means one new equity share for every existing fully paid-up share held on the record date.
What the record date means
The record date decides which shareholders get the bonus shares. Anyone holding the shares on that date is eligible. A holder of 100 shares on the record date would, under a 1:1 bonus and all else being equal, hold 200 shares after the issue.
Concord Biotech bonus issue background
The company disclosed the bonus plan on 23 September 2026, according to the record-date filing, which refers to that earlier disclosure. The board then fixed the record date at its meeting on 27 October 2026. The filing says the bonus is subject to statutory and regulatory approvals, as applicable.
Allotment date
The filing says Thursday, 5 November 2026, will be the deemed date of allotment of the bonus shares, the day after the record date. It does not state the ex-bonus date or the date the new shares will be credited to demat accounts; those come in the exchange notices.
Other companies in the same record-date week
Companies with record dates in the same week include Infosys and Asian Paints. For more corporate-action and results coverage, see the results news page.
What to watch next
Watch the exchange notice on the credit of the bonus shares, and the company’s next update on the bonus issue after the record date.
This article is a summary for information only and is not investment advice. Figures are as reported by the sources above; please verify with the original filing or report before making any decision.